Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic
Sue Pavord, Thachil Jecko, Beverley J. Hunt, Michael Murphy, Gillian Lowe, Mike Laffan, Mike Makris, Adrian C. Newland, Drew Provan, John D. Grainger, Quentin A. Hill
Abstract
This document aims to provide practical guidance for the assessment and management of patients with thrombocytopenia, with a particular focus on immune thrombocytopenia (ITP), during the COVID-19 pandemic. The intention is to support clinicians and, although recommendations have been provided, it is not a formal guideline. Nor is there sufficient evidence base to conclude that alternative approaches to treatment are incorrect. Instead, it is a consensus written by clinicians with an interest in ITP or coagulation disorders and reviewed by members of the UK ITP forum.
Topics & Concepts
Immune thrombocytopeniaPandemicGuidelineCoronavirus disease 2019 (COVID-19)MedicineIntensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEImmunologyPlateletVirologyInternal medicineDiseasePathologyPolitical scienceOutbreakInfectious disease (medical specialty)LawPlatelet Disorders and TreatmentsBlood properties and coagulationBlood groups and transfusion